---
title: "Dersimelagon (MT-7117) in Erythropoietic protoporphyria or X-linked protoporphyria: cost-effectiveness analyses and utility weights"
description: "Published cost-effectiveness analyses and health-state utility weights for Dersimelagon (MT-7117) in Erythropoietic protoporphyria or X-linked protoporphyria, each value quoted from the article: 0 cost-effectiveness analyses and 0 studies reporting utility weights. Every value is a verbatim quote from the primary article it is shown with."
canonical: "https://www.evicenter.com/drugs/dersimelagon--erythropoietic-protoporphyria-or-x-linked-protoporphyria/cost-effectiveness-analyses"
published: "2026-10-22T07:49:06-04:00"
modified: "2026-10-22T07:49:06-04:00"
---

# Dersimelagon (MT-7117) in Erythropoietic protoporphyria or X-linked protoporphyria: cost-effectiveness analyses and utility weights

Published cost-effectiveness analyses and health-state utility weights that a model of this product could cite, adapt, or compare against, grouped by how each article relates to the product and its indication. Every value is quoted from the article it cites, and section 3 lists the searches that found the articles.

<a id="cost-effectiveness-analyses-overview"></a>

## Overview

<a id="cost-effectiveness-analyses-topic-overview-1"></a>

| Item | Detail |
| --- | --- |
| Literature searched | Tufts Medical Center Cost-Effectiveness Analysis Registry, searched October 21, 2026; the queries are listed in section 3. |
| Cost-effectiveness analyses | 0 |
| Studies reporting utility weights | 0 |

<a id="cost-effectiveness-analyses-cost-effectiveness-analyses"></a>

## 1 Cost-effectiveness analyses

<a id="cost-effectiveness-analyses-heading-1.1"></a>

### 1.1 Analyses of Dersimelagon (MT-7117)

No evidence found.

<a id="cost-effectiveness-analyses-heading-1.2"></a>

### 1.2 Treatments for the same indication

No evidence found.

<a id="cost-effectiveness-analyses-heading-1.3"></a>

### 1.3 The same disease in other populations or settings

No evidence found.

<a id="cost-effectiveness-analyses-heading-1.4"></a>

### 1.4 Related diseases and analogous treatments

No evidence found.

<a id="cost-effectiveness-analyses-utility-weights"></a>

## 2 Utility weights

<a id="cost-effectiveness-analyses-heading-2.1"></a>

### 2.1 Utility weights from analyses of Dersimelagon (MT-7117)

No evidence found.

<a id="cost-effectiveness-analyses-heading-2.2"></a>

### 2.2 Utility weights for the same indication

No evidence found.

<a id="cost-effectiveness-analyses-heading-2.3"></a>

### 2.3 Utility weights for the same disease in other populations or settings

No evidence found.

<a id="cost-effectiveness-analyses-heading-2.4"></a>

### 2.4 Utility weights for related diseases and analogous treatments

No evidence found.

<a id="cost-effectiveness-analyses-search-strategy"></a>

## 3 Search strategy

<a id="cost-effectiveness-analyses-topic-3-1"></a>

| Dataset | Query | Results |
| --- | --- | --- |
| Ratios | dersimelagon OR "MT-7117" OR afamelanotide OR Scenesse OR protoporphyria | 0 |
| Methods | dersimelagon OR afamelanotide OR protoporphyria OR "melanocortin" | 0 |
| Weights | protoporphyria OR porphyria OR afamelanotide OR "phototoxicity" OR "photosensitivity" | 1 |
| Ratios | givosiran OR "acute hepatic porphyria" OR "acute intermittent porphyria" OR hemin | 0 |
| Ratios | vitiligo OR "polymorphous light eruption" OR "polymorphic light eruption" OR "solar urticaria" | 0 |
| Weights | "DLQI" OR "Dermatology Life Quality Index" | 9 |
| Ratios | porphyria OR "erythropoietic" | 4 |
| Methods | porphyria OR "light sensitivity" OR "sunlight exposure" | 0 |

## Related pages
- [Dersimelagon (MT-7117): Erythropoietic protoporphyria or X-linked protoporphyria](https://www.evicenter.com/drugs/dersimelagon--erythropoietic-protoporphyria-or-x-linked-protoporphyria) · [Markdown](https://www.evicenter.com/drugs/dersimelagon--erythropoietic-protoporphyria-or-x-linked-protoporphyria.md)
- [Dersimelagon (MT-7117) in Erythropoietic protoporphyria or X-linked protoporphyria: Terms and abbreviations](https://www.evicenter.com/drugs/dersimelagon--erythropoietic-protoporphyria-or-x-linked-protoporphyria/terms-and-abbreviations) · [Markdown](https://www.evicenter.com/drugs/dersimelagon--erythropoietic-protoporphyria-or-x-linked-protoporphyria/terms-and-abbreviations.md)
- [Dersimelagon (MT-7117): Erythropoietic protoporphyria or X-linked protoporphyria](https://www.evicenter.com/drugs/dersimelagon--erythropoietic-protoporphyria-or-x-linked-protoporphyria/executive-summary) · [Markdown](https://www.evicenter.com/drugs/dersimelagon--erythropoietic-protoporphyria-or-x-linked-protoporphyria/executive-summary.md)
- [Dersimelagon (MT-7117) in Erythropoietic protoporphyria or X-linked protoporphyria: Product information and disease description](https://www.evicenter.com/drugs/dersimelagon--erythropoietic-protoporphyria-or-x-linked-protoporphyria/product-information-and-disease-description) · [Markdown](https://www.evicenter.com/drugs/dersimelagon--erythropoietic-protoporphyria-or-x-linked-protoporphyria/product-information-and-disease-description.md)
- [Dersimelagon (MT-7117) in Erythropoietic protoporphyria or X-linked protoporphyria: Clinical evidence](https://www.evicenter.com/drugs/dersimelagon--erythropoietic-protoporphyria-or-x-linked-protoporphyria/clinical-evidence) · [Markdown](https://www.evicenter.com/drugs/dersimelagon--erythropoietic-protoporphyria-or-x-linked-protoporphyria/clinical-evidence.md)
- [Dersimelagon (MT-7117) in Erythropoietic protoporphyria or X-linked protoporphyria: Economic information and modeling report](https://www.evicenter.com/drugs/dersimelagon--erythropoietic-protoporphyria-or-x-linked-protoporphyria/economics) · [Markdown](https://www.evicenter.com/drugs/dersimelagon--erythropoietic-protoporphyria-or-x-linked-protoporphyria/economics.md)
- [Dersimelagon (MT-7117) in Erythropoietic protoporphyria or X-linked protoporphyria: References](https://www.evicenter.com/drugs/dersimelagon--erythropoietic-protoporphyria-or-x-linked-protoporphyria/references) · [Markdown](https://www.evicenter.com/drugs/dersimelagon--erythropoietic-protoporphyria-or-x-linked-protoporphyria/references.md)
- [Dersimelagon (MT-7117) in Erythropoietic protoporphyria or X-linked protoporphyria: prevalence by geography](https://www.evicenter.com/drugs/dersimelagon--erythropoietic-protoporphyria-or-x-linked-protoporphyria/prevalence) · [Markdown](https://www.evicenter.com/drugs/dersimelagon--erythropoietic-protoporphyria-or-x-linked-protoporphyria/prevalence.md)